Genscript Biotech

Genscript Biotech Tangible Book Value per Share

The Tangible Book Value per Share of Genscript Biotech (1548.HK) as of Oct 6, 2026 is 1.83 USD. In the previous year, Tangible Book Value per Share was 1.99 USD — a change of -8.39% (lower).

Tangible Book Value per Share

1.83USD

YoY

-8.39%

Last updated:

Tangible Book Value per Share of Genscript Biotech is 2026 1.83 USD. Tangible Book Value per Share of Genscript Biotech was 2025 1.99 USD. It decreases by -8.39% lower compared to the previous year.

The Genscript Biotech Tangible Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Tangible Book Value per Share
Date
Tangible Book Value per Share
Jan 1, 2018
0.20 USD
Jan 1, 2019
0.16 USD
Jan 1, 2020
0.40 USD
Jan 1, 2021
0.46 USD
Jan 1, 2022
0.45 USD
Jan 1, 2023
0.64 USD
Jan 1, 2024
1.99 USD
Jan 1, 2025
1.83 USD
The Genscript Biotech Tangible Book Value per Share history
YEARTangible Book Value per ShareYoY
1.83USD-8.39%
1.99USD+210.84%
0.64USD+41.21%
0.45USD-2.11%
0.46USD+16.70%
0.40USD+151.86%
0.16USD-22.91%
0.20USD+107.48%
0.10USD+22.85%
0.08USD+17.36%
0.07USD+141.55%
0.03USD-34.86%
0.04USD+18.53%
0.04USD—
Access this data via the Eulerpool API
Get Free API Key

Genscript Biotech Stock analysis

What does Genscript Biotech do? GenScript Biotech Corp. is a leading biotechnology company founded in Nanjing, China in 2002. Today, it is headquartered in New Jersey, USA and operates worldwide. Genscript Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genscript Biotech stock

Tangible Book Value per Share of Genscript Biotech is 1.83 USD in 2026.

Tangible Book Value per Share of Genscript Biotech changed from 1.99 USD to 1.83 USD, representing a -8.39% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Tangible Book Value per Share Genscript Biotech since 2006 – with annual values, charts, and detailed analysis.

Tangible book value per share excludes intangible assets and goodwill, providing a more conservative measure of per-share net asset value.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Genscript Biotech

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Genscript Biotech